Question
What is safer, 503A or 503B?
Short answer
Both operate safely within their regulatory categories: 503B facilities under FDA cGMP inspection, 503A pharmacies under state board oversight and USP 797/800 compounding standards. The "safer" question is the wrong framing - the question is which regulatory category matches the use case, and the insurance program must satisfy whatever contract obligations result.
The regulatory distinction
503A pharmacies compound patient-specific prescriptions under state pharmacy board oversight and federal USP <797> sterile compounding and <800> hazardous drug standards. They cannot sell compounded preparations to hospitals or clinics without patient-specific prescriptions and are not subject to FDA cGMP inspection.
503B outsourcing facilities compound office-use product for hospitals and clinics without patient-specific prescriptions, under FDA registration and ongoing cGMP inspection. They can supply meaningful volume to hospital and clinic systems but must operate at substantially higher infrastructure and compliance cost than a 503A pharmacy.
What it means for insurance
A 503A pharmacy's insurance program is built around druggist professional liability (for prescription errors), products liability scaled to compounded product volume, USP 797/800 compliance discipline, and HIPAA-driven cyber. Premium for a Texas 503A in the $5M-$15M revenue range typically runs $25,000-$80,000 annually.
A 503B facility's program looks closer to a small-molecule CDMO: higher products liability limits, hospital additional-insured and GPO supplier endorsements, dedicated recall coverage, and cGMP-specific property/business interruption. Premium typically runs $100,000-$300,000+ annually for facilities in the $10M-$50M revenue range.
Primary sources
Sources and references
This answer draws on the following regulatory, statutory, and standards-body sources. Coverage availability and program structure also depend on carrier appetite and underwriter discretion not captured by these sources.
- FDA - Compounding and the FD&C Acthttps://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- USP <797> Sterile Compoundinghttps://www.usp.org/compounding/general-chapter-797
- USP <800> Hazardous Drugshttps://www.usp.org/compounding/general-chapter-hazardous-drugs-handling-healthcare
Related practice areas
Insurance clauses in this area
Related questions
Have a more specific question?
A specialist will reach out by the end of the day.
Request a free coverage review